Overview
Meghan Maclean is a Palliative Medicine provider practicing medicine in Lebanon, Pennsylvania.
Her clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
252 S 4th St, Lebanon, PA 17042
Lancaster General Hospital
Monika Holbein is a Palliative Medicine provider practicing medicine in Lancaster, Pennsylvania. Dr. Holbein is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Pediatric Low-Grade Glioma (pLGG), and Opioid Induced Constipation.
WellSpan Ephrata Community Hospital
Govindbhai Kachhadiya is a Palliative Medicine provider practicing medicine in Ephrata, Pennsylvania. Dr. Kachhadiya is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Heart Failure with Preserved Ejection Fraction (HFpEF), End-Stage Renal Disease (ESRD), Chronic Inflammatory Response Syndrome (CIRS), Ureteroscopy, and Hip Replacement.
Hosana Healthcare Solutions LLC
Jennifer Legar is a Palliative Medicine provider practicing medicine in Center Valley, Pennsylvania. She has been practicing medicine for over 17 years. Dr. Legar is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Heart Failure with Preserved Ejection Fraction (HFpEF), Protein Deficiency, Relapsing Multiple Sclerosis (RMS), and Chronic Pain.
Frequently Asked Questions about Dr. Meghan E. Maclean
How do I make an appointment with Dr. Meghan E. Maclean?
You can book an appointment with Dr. Meghan E. Maclean by calling their office at 717-639-3150. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Meghan E. Maclean a top-rated expert for ALK-Positive Non-Small Cell Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Meghan E. Maclean is classified as an Experienced expert for ALK-Positive Non-Small Cell Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Meghan E. Maclean specialize in?
While Dr. Meghan E. Maclean is a Palliative Medicine, they have specific expertise in ALK-Positive Non-Small Cell Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Palliative Medicine.
Does Dr. Meghan E. Maclean accept my insurance?
Dr. Meghan E. Maclean accepts most major insurance plans, including Aetna and Capital Blue Cross. We recommend calling the office directly at 717-639-3150 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ALK-Positive Non-Small Cell Lung CancerDr. Maclean isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.